Education
About Us
Working with TipRanks
Follow Us
Kestra Medical Technologies Ltd. (KMTS)
NASDAQ:KMTS
KMTS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$20.00 - $26.06
Previous CloseN/A
VolumeN/A
Average Volume (3M)473.24K
Market Cap
$1.19B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta6.93
Next Earnings
Apr 14, 2025EPS Estimate
-0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.89
Shares Outstanding49,533,817
10 Day Avg. Volume220,276
30 Day Avg. Volume473,237
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bulls Say, Bears Say
Bulls Say
Market ExpansionKMTS's wearable cardioverter defibrillator (WCD) has advantages over its sole competitor, which will enable it to expand its market share from ~5% in FY25 to at least ~16% in FY29.
Product DifferentiationAssure, the WCD developed by KMTS, is more comfortable to wear, has significantly fewer false alarms, and comes in both male and female versions, improving patient compliance.
Bears Say
Competitive ChallengesThere is a challenge in displacing the incumbent competitor, Zoll, which has been in the market for over 20 years.
Regulatory LimitationsWCDs are currently Class 2 recommended, which means they 'should or may' be considered by clinicians, potentially limiting adoption.
---
KMTS FAQ
What was Kestra Medical Technologies Ltd.’s price range in the past 12 months?
Kestra Medical Technologies Ltd. lowest stock price was $20.00 and its highest was $26.06 in the past 12 months.
What is Kestra Medical Technologies Ltd.’s market cap?
Kestra Medical Technologies Ltd.’s market cap is $1.19B.
When is Kestra Medical Technologies Ltd.’s upcoming earnings report date?
Kestra Medical Technologies Ltd.’s upcoming earnings report date is Apr 14, 2025 which is in 9 days.
How were Kestra Medical Technologies Ltd.’s earnings last quarter?
Currently, no data Available
Is Kestra Medical Technologies Ltd. overvalued?
According to Wall Street analysts Kestra Medical Technologies Ltd.’s price is currently Overvalued.
Does Kestra Medical Technologies Ltd. pay dividends?
Kestra Medical Technologies Ltd. does not currently pay dividends.
What is Kestra Medical Technologies Ltd.’s EPS estimate?
Kestra Medical Technologies Ltd.’s EPS estimate is -0.6.
How many shares outstanding does Kestra Medical Technologies Ltd. have?
Kestra Medical Technologies Ltd. has 49,533,817 shares outstanding.
What happened to Kestra Medical Technologies Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kestra Medical Technologies Ltd.?
Currently, no hedge funds are holding shares in KMTS
---
Company Description
Kestra Medical Technologies Ltd.
Kestra Medical Technologies is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest. The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient's heart to normal rhythm.
---
KMTS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering KMTS
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-3.60%
initiated a buy rating 5 days ago
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.60% per trade.
---